YARROW BIOSCIENCE INC

Historical 13F Holders

Symbol
YARW
CUSIP
92941V407
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 92941V407 since 12/18/2024, largest first.

Filer % of Class Filed
Bellevue Group AG 13G
10.6% 10/7/2026
Event 9/10/2026
Perceptive Advisors LLC 13G/A
10.0% 11/16/2026
Event 9/30/2026
venBio Global Strategic Fund V, L.P. 13G/A
10.0% 11/16/2026
Event 9/30/2026
Logos Global Management LP 13G/A
10.0% 11/17/2026
Event 9/30/2026
Orbimed Advisors LLC 13D
10.0% 8/5/2026
Event 7/27/2026
RTW Fund Group GP, LLC 13G/A
9.9% 11/16/2026
Event 9/30/2026
Ameriprise Financial, Inc. 13G
8.6% 11/16/2026
Event 9/30/2026
Invus Global Management, LLC 13G
7.2% 9/17/2026
Event 9/11/2026
Spruce Street Capital LP 13G
6.4% 11/13/2026
Event 9/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (5)
Janus Henderson Group Ltd. 13G/A 3.0% 11/16/2026
Event 9/30/2026
ADAR1 Capital Management, LLC 13G/A
2.5% 11/16/2026
Event 9/30/2026
AI Biotechnology LLC 13D/A
1.2% 11/20/2026
Event 11/13/2026
Zhang Xiaofan 13G/A 0.6% 8/13/2026
Event 8/13/2026
Nantahala Capital Management, LLC 13G/A
0.5% 11/13/2026
Event 9/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 49 9.42 M $212M